Melissa Anne Cunningham, M.D., Ph.D.

Accepting New Patients

Accepting New Patients

Provider Image

4.9 out of 5 (43 ratings)

New Patients

843-792-9200 843-792-9200

15 day(s) until next new
patient appointment as of
8:30 a.m. .

What is this?


If the time frame shown for a new patient appointment for this provider is not convenient, please call 843-792-9200 for an appointment with one of their colleagues.

Returning Patients

843-792-9200 843-792-9200

Degree M.D., Ph.D.
School Penn State College of Medicine
Residency
  • Medical University of South Carolina
Fellowship
  • Medical University of South Carolina
Board Certification
  • Internal Medicine: Rheumatology
Specialties
  • Rheumatology & Immunology
Accepts New Patients Yes

New Patients

843-792-9200 843-792-9200

15 day(s) until next new
patient appointment as of
8:30 a.m. 12/17/2017.

What is this?


If the time frame shown for a new patient appointment for this provider is not convenient, please call 843-792-9200 for an appointment with one of their colleagues.
To request an appointment call our representatives at 843-792-1414

Returning Patients

843-792-9200 843-792-9200

Locations

West Ashley Medical Pavilion
2125 Charlie Hall Boulevard
Charleston, SC 29414
Map & Directions
Rutledge Tower
135 Rutledge Avenue
Charleston, SC 29425
Map & Directions
 

Biography

Dr. Melissa Cunningham was raised in Hershey, Pennsylvania. She received her undergraduate degree from Dartmouth College and a Masters degree in molecular medicine from Boston University. After receiving her M.D. and Ph.D. degrees at Pennsylvania State University, she entered the ABIM’s clinician-scientist track at the Medical University of South Carolina, where she completed her residency and fellowship training in June 2012, and subsequently joined the faculty as an assistant professor in the division of rheumatology and immunology.

Dr. Cunningham's group has a particular interest in inflammation, autoimmunity, and sex bias. Her research is focused on systemic lupus erythematosus (SLE) and the role of estrogen receptor alpha (ERa) in modulating the inflammatory response in this disease, which is predominately diagnosed in females (9:1 vs. males). Her work has been supported by MUSC’s specialized center of research on sex and gender factors affecting women’s health, a grant from MUSC's center for genomic medicine and a three-year CTSA KL2 award. She is currently funded on a five-year NIH career development award (K08).